Skip to main content
. Author manuscript; available in PMC: 2024 Sep 22.
Published in final edited form as: J Nat Prod. 2023 Aug 29;86(9):2102–2110. doi: 10.1021/acs.jnatprod.3c00186

Figure 6.

Figure 6.

(A, B) The sensitivity of OVCAR3 cells to ferroptosis induction with RSL3 and IKE was validated. (C) The cytotoxicity induced by eupenifeldin treatment was not reversed by ferrostatin-1 addition, implicating that a nonferroptotic death pathway is involved. (D) The ability of eupenifeldin to induce lipid peroxidation was tested, and no increase in lipid peroxidation was observed.